<VariationArchive VariationID="1112" VariationName="NM_025137.4(SPG11):c.733_734del (p.Met245fs)" VariationType="Deletion" Accession="VCV000001112" Version="75" RecordType="classified" NumberOfSubmissions="21" NumberOfSubmitters="19" DateLastUpdated="2024-07-29" DateCreated="2013-05-03" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="16151" VariationID="1112">
      <GeneList>
        <Gene Symbol="SPG11" FullName="SPG11 vesicle trafficking associated, spatacsin" GeneID="80208" HGNC_ID="HGNC:11226" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="44562696" stop="44663662" display_start="44562696" display_stop="44663662" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="44854893" stop="44955875" display_start="44854893" display_stop="44955875" Strand="-" />
          </Location>
          <OMIM>610844</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_025137.4(SPG11):c.733_734del (p.Met245fs)</Name>
      <CanonicalSPDI>NC_000015.10:44657229:AT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="44657230" stop="44657231" display_start="44657230" display_stop="44657231" variantLength="2" positionVCF="44657229" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="44949428" stop="44949429" display_start="44949428" display_stop="44949429" variantLength="2" positionVCF="44949427" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>M245fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.44657230_44657231del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.44657230_44657231del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.44949428_44949429del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.44949428_44949429del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008885.1" sequenceAccession="NG_008885" sequenceVersion="1" change="g.11448_11449del">
            <Expression>NG_008885.1:g.11448_11449del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001160227.2" sequenceAccession="NM_001160227" sequenceVersion="2" change="c.733_734del">
            <Expression>NM_001160227.2:c.733_734del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153699.1" sequenceAccession="NP_001153699" sequenceVersion="1" change="p.Met245fs">
            <Expression>NP_001153699.1:p.Met245fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025137.4" sequenceAccession="NM_025137" sequenceVersion="4" change="c.733_734del" MANESelect="true">
            <Expression>NM_025137.4:c.733_734del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079413.3" sequenceAccession="NP_079413" sequenceVersion="3" change="p.Met245fs">
            <Expression>NP_079413.3:p.Met245fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025137.4" sequenceAccession="NM_025137" sequenceVersion="4" change="c.733_734delAT" MANESelect="true">
            <Expression>NM_025137.4:c.733_734delAT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001160227.1" sequenceAccession="NM_001160227" sequenceVersion="1" change="c.733_734del">
            <Expression>NM_001160227.1:c.733_734del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA277189" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="610844.0004" DB="OMIM" />
        <XRef Type="rs" ID="312262720" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00005" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00006" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00007" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00011" Source="Exome Aggregation Consortium (ExAC)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_025137.4(SPG11):c.733_734del (p.Met245fs) AND Hereditary spastic paraplegia 11" Accession="RCV000001171" Version="32">
        <ClassifiedConditionList TraitSetID="295">
          <ClassifiedCondition DB="MedGen" ID="C1858479">Hereditary spastic paraplegia 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-09" SubmissionCount="10">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025137.4(SPG11):c.733_734del (p.Met245fs) AND Amyotrophic lateral sclerosis type 5" Accession="RCV000193699" Version="10">
        <ClassifiedConditionList TraitSetID="22812">
          <ClassifiedCondition DB="MedGen" ID="C1865864">Amyotrophic lateral sclerosis type 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2010-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025137.4(SPG11):c.733_734del (p.Met245fs) AND not provided" Accession="RCV000256068" Version="12">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-11-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025137.4(SPG11):c.733_734del (p.Met245fs) AND Hereditary spastic paraplegia" Accession="RCV000515921" Version="13">
        <ClassifiedConditionList TraitSetID="8750">
          <ClassifiedCondition DB="MedGen" ID="C0037773">Hereditary spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-08-11" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025137.4(SPG11):c.733_734del (p.Met245fs) AND Inborn genetic diseases" Accession="RCV001266812" Version="11">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-01-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025137.4(SPG11):c.733_734del (p.Met245fs) AND Abnormal central motor function" Accession="RCV001813928" Version="8">
        <ClassifiedConditionList TraitSetID="70045">
          <ClassifiedCondition DB="MedGen" ID="C4023354">Abnormal central motor function</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025137.4(SPG11):c.733_734del (p.Met245fs) AND multiple conditions" Accession="RCV001535461" Version="9">
        <ClassifiedConditionList TraitSetID="44618">
          <ClassifiedCondition DB="MedGen" ID="C1865864">Amyotrophic lateral sclerosis type 5</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1858479">Hereditary spastic paraplegia 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025137.4(SPG11):c.733_734del (p.Met245fs) AND multiple conditions" Accession="RCV002476906" Version="8">
        <ClassifiedConditionList TraitSetID="35301">
          <ClassifiedCondition DB="MedGen" ID="C1865864">Amyotrophic lateral sclerosis type 5</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C5569024">Charcot-Marie-Tooth disease axonal type 2X</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1858479">Hereditary spastic paraplegia 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025137.4(SPG11):c.733_734del (p.Met245fs) AND Charcot-Marie-Tooth disease axonal type 2X" Accession="RCV002288458" Version="10">
        <ClassifiedConditionList TraitSetID="23391">
          <ClassifiedCondition DB="MedGen" ID="C5569024">Charcot-Marie-Tooth disease axonal type 2X</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-01-21" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-09" NumberOfSubmissions="21" NumberOfSubmitters="19" DateCreated="2013-05-03" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17322883</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17717710</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18067136</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18079167</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18332254</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18835492</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19105190</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19438933</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20110243</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22154821</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22175763</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22237444</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22696581</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24833714</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26556829</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27071356</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28832565</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29980238</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31289639</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301389</ID>
          <ID Source="BookShelf">NBK1210</ID>
        </Citation>
        <DescriptionHistory Dated="2018-05-29">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-01-27">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="70045" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="29342" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Abnormal central motor function</ElementValue>
                <XRef ID="HP:0011442" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C4023354" DB="MedGen" />
              <XRef Type="primary" ID="HP:0011442" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="22812" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="219" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE</ElementValue>
                <XRef Type="MIM" ID="602099" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Amyotrophic lateral sclerosis type 5</ElementValue>
                <XRef ID="MONDO:0011196" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ALS5</ElementValue>
                <XRef Type="MIM" ID="602099" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15343" />
                <XRef ID="15343" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10503" />
                <XRef ID="10503" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301623</ID>
                <ID Source="BookShelf">NBK1450</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_AmyotrophicLateralSclerosis.pdf</URL>
                <CitationText>Orphanet, Amyotrophic lateral sclerosis, 2007</CitationText>
              </Citation>
              <XRef ID="300605" DB="Orphanet" />
              <XRef ID="C1865864" DB="MedGen" />
              <XRef ID="MONDO:0011196" DB="MONDO" />
              <XRef Type="MIM" ID="602099" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8750" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14327" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia</ElementValue>
                <XRef ID="Hereditary+spastic+paraplegia/3383" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019064" DB="MONDO" />
                <XRef ID="39912006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial spastic paraparesis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HSP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FSP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000500218" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525863" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592992" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529007" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576334" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500041" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525862" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508756" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6637" />
                <XRef ID="6637" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301682</ID>
                <ID Source="BookShelf">NBK1509</ID>
              </Citation>
              <XRef ID="685" DB="Orphanet" />
              <XRef ID="C0037773" DB="MedGen" />
              <XRef ID="MONDO:0019064" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS303350" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="44618" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3739" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 11</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary spastic paraplegia mental impairment and thin corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 11</ElementValue>
                <XRef ID="MONDO:0011445" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nakamura Osame syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autosomal recessive hereditary spastic paraplegia, mental impairment, and thin corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUS CALLOSUM</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT AND THIN CORPUS CALLOSUM</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia,  mental retardation and thin corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 11, autosomal recessive</ElementValue>
                <XRef ID="Spastic+paraplegia+11/6677" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HSP-TCC</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SPG11</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Spastic paraplegia 11 (SPG11) is characterized by progressive spasticity and weakness of the lower limbs frequently associated with the following: mild intellectual disability with learning difficulties in childhood and/or progressive cognitive decline; peripheral neuropathy; pseudobulbar involvement; and increased reflexes in the upper limbs. Less frequent findings include: cerebellar signs (ataxia, nystagmus, saccadic pursuit); retinal degeneration; pes cavus; scoliosis; and parkinsonism with characteristic brain MRI features that include thinning of the corpus callosum. Onset occurs mainly during infancy or adolescence (range: age 1-31 years) and in rare cases as late as age 60 years. Most affected individuals become wheelchair bound one or two decades after disease onset.</Attribute>
                <XRef ID="NBK1210" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4919" />
                <XRef ID="4919" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301389</ID>
                <ID Source="BookShelf">NBK1210</ID>
              </Citation>
              <XRef ID="2822" DB="Orphanet" />
              <XRef ID="C1858479" DB="MedGen" />
              <XRef ID="MONDO:0011445" DB="MONDO" />
              <XRef Type="MIM" ID="604360" DB="OMIM" />
            </Trait>
            <Trait ID="219" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE</ElementValue>
                <XRef Type="MIM" ID="602099" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Amyotrophic lateral sclerosis type 5</ElementValue>
                <XRef ID="MONDO:0011196" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ALS5</ElementValue>
                <XRef Type="MIM" ID="602099" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15343" />
                <XRef ID="15343" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10503" />
                <XRef ID="10503" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301623</ID>
                <ID Source="BookShelf">NBK1450</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_AmyotrophicLateralSclerosis.pdf</URL>
                <CitationText>Orphanet, Amyotrophic lateral sclerosis, 2007</CitationText>
              </Citation>
              <XRef ID="300605" DB="Orphanet" />
              <XRef ID="C1865864" DB="MedGen" />
              <XRef ID="MONDO:0011196" DB="MONDO" />
              <XRef Type="MIM" ID="602099" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="35301" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34433" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2X</ElementValue>
                <XRef Type="MIM" ID="616668" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2X</ElementValue>
                <XRef Type="MIM" ID="616668" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Charcot-Marie-Tooth disease axonal type 2X</ElementValue>
                <XRef ID="MONDO:0014726" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMT2X</ElementValue>
                <XRef Type="MIM" ID="616668" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17830" />
                <XRef ID="17830" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="466775" DB="Orphanet" />
              <XRef ID="C5569024" DB="MedGen" />
              <XRef ID="MONDO:0014726" DB="MONDO" />
              <XRef Type="MIM" ID="616668" DB="OMIM" />
            </Trait>
            <Trait ID="3739" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 11</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary spastic paraplegia mental impairment and thin corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 11</ElementValue>
                <XRef ID="MONDO:0011445" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nakamura Osame syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autosomal recessive hereditary spastic paraplegia, mental impairment, and thin corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUS CALLOSUM</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT AND THIN CORPUS CALLOSUM</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia,  mental retardation and thin corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 11, autosomal recessive</ElementValue>
                <XRef ID="Spastic+paraplegia+11/6677" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HSP-TCC</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SPG11</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Spastic paraplegia 11 (SPG11) is characterized by progressive spasticity and weakness of the lower limbs frequently associated with the following: mild intellectual disability with learning difficulties in childhood and/or progressive cognitive decline; peripheral neuropathy; pseudobulbar involvement; and increased reflexes in the upper limbs. Less frequent findings include: cerebellar signs (ataxia, nystagmus, saccadic pursuit); retinal degeneration; pes cavus; scoliosis; and parkinsonism with characteristic brain MRI features that include thinning of the corpus callosum. Onset occurs mainly during infancy or adolescence (range: age 1-31 years) and in rare cases as late as age 60 years. Most affected individuals become wheelchair bound one or two decades after disease onset.</Attribute>
                <XRef ID="NBK1210" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4919" />
                <XRef ID="4919" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301389</ID>
                <ID Source="BookShelf">NBK1210</ID>
              </Citation>
              <XRef ID="2822" DB="Orphanet" />
              <XRef ID="C1858479" DB="MedGen" />
              <XRef ID="MONDO:0011445" DB="MONDO" />
              <XRef Type="MIM" ID="604360" DB="OMIM" />
            </Trait>
            <Trait ID="219" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE</ElementValue>
                <XRef Type="MIM" ID="602099" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Amyotrophic lateral sclerosis type 5</ElementValue>
                <XRef ID="MONDO:0011196" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ALS5</ElementValue>
                <XRef Type="MIM" ID="602099" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15343" />
                <XRef ID="15343" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10503" />
                <XRef ID="10503" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301623</ID>
                <ID Source="BookShelf">NBK1450</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_AmyotrophicLateralSclerosis.pdf</URL>
                <CitationText>Orphanet, Amyotrophic lateral sclerosis, 2007</CitationText>
              </Citation>
              <XRef ID="300605" DB="Orphanet" />
              <XRef ID="C1865864" DB="MedGen" />
              <XRef ID="MONDO:0011196" DB="MONDO" />
              <XRef Type="MIM" ID="602099" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="295" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3739" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 11</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary spastic paraplegia mental impairment and thin corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 11</ElementValue>
                <XRef ID="MONDO:0011445" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nakamura Osame syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autosomal recessive hereditary spastic paraplegia, mental impairment, and thin corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUS CALLOSUM</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT AND THIN CORPUS CALLOSUM</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia,  mental retardation and thin corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 11, autosomal recessive</ElementValue>
                <XRef ID="Spastic+paraplegia+11/6677" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HSP-TCC</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SPG11</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Spastic paraplegia 11 (SPG11) is characterized by progressive spasticity and weakness of the lower limbs frequently associated with the following: mild intellectual disability with learning difficulties in childhood and/or progressive cognitive decline; peripheral neuropathy; pseudobulbar involvement; and increased reflexes in the upper limbs. Less frequent findings include: cerebellar signs (ataxia, nystagmus, saccadic pursuit); retinal degeneration; pes cavus; scoliosis; and parkinsonism with characteristic brain MRI features that include thinning of the corpus callosum. Onset occurs mainly during infancy or adolescence (range: age 1-31 years) and in rare cases as late as age 60 years. Most affected individuals become wheelchair bound one or two decades after disease onset.</Attribute>
                <XRef ID="NBK1210" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4919" />
                <XRef ID="4919" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301389</ID>
                <ID Source="BookShelf">NBK1210</ID>
              </Citation>
              <XRef ID="2822" DB="Orphanet" />
              <XRef ID="C1858479" DB="MedGen" />
              <XRef ID="MONDO:0011445" DB="MONDO" />
              <XRef Type="MIM" ID="604360" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="23391" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34433" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2X</ElementValue>
                <XRef Type="MIM" ID="616668" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2X</ElementValue>
                <XRef Type="MIM" ID="616668" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Charcot-Marie-Tooth disease axonal type 2X</ElementValue>
                <XRef ID="MONDO:0014726" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMT2X</ElementValue>
                <XRef Type="MIM" ID="616668" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17830" />
                <XRef ID="17830" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="466775" DB="Orphanet" />
              <XRef ID="C5569024" DB="MedGen" />
              <XRef ID="MONDO:0014726" DB="MONDO" />
              <XRef Type="MIM" ID="616668" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1333315" SubmissionDate="2018-01-26" DateLastUpdated="2017-12-26" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="SUB3428844" submittedAssembly="GRCh37" title="SUB3428844" />
        <ClinVarAccession Accession="SCV000678246" DateUpdated="2017-12-26" DateCreated="2017-12-26" Type="SCV" Version="1" SubmitterName="Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics" OrgID="505565" OrganizationCategory="other" OrgAbbreviation="FRIGE - IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The observed variant c.733_734delAT (p.M245Vfs) is not reported in The 1000 Genomes database and its minor allele frequency in ExAC database is 0.0001071. The in silico prediction for the variant is pathogenic by MutationTaster2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Gujarati Hindu</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">20</Age>
              <Age Type="maximum" age_unit="years">29</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>Illumina Sequencing Platform</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <Description>DNA isolated from blood was used to perform targeted gene capture using a custom capture kit. The libraries were sequenced to mean &gt;80-100X coverage on Illumina sequencing platform. The sequence obtained was aligned to the human reference genome (GRCh37/hg19) using BWA program and analyzed using Picard and GATK-Lite toolkit to identify variants in the targeted gene relevant to clinical indication.</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="Human Phenotype Ontology" ID="HP:0002355" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="Human Phenotype Ontology" ID="HP:0002061" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11">
              <Name>SPG11, spatacsin vesicle trafficking associated</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_025137.3:exon 4</GeneLocation>
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">D-3758</Name>
            <Name>p.M245Vfs</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="dbSNP" ID="rs312262720" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.3:c.733_734delAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604360" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3428844</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="21321" SubmissionDate="2019-05-17" DateLastUpdated="2019-05-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="610844.0004_SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE" title="SPG11, 2-BP DEL, 733AT_SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE" />
        <ClinVarAccession Accession="SCV000021321" DateUpdated="2019-05-20" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 27-year-old Italian opposite-sex dizygotic twins with autosomal recessive spastic paraplegia-11 (SPG11; 604360), Del Bo et al. (2007) identified a homozygous 2-bp deletion (733delAT) in exon 4 of the SPG11 gene, resulting in a frameshift and premature termination at codon 247. The sibs had onset of ataxia and cognitive impairment at ages 12 and 15 years, respectively. The disorder progressed rapidly, leading to spastic paraplegia, dysarthria, and peripheral neuropathy. Both were wheelchair-bound in their early twenties. Brain MRI showed thin corpus callosum and cortical atrophy in both sibs. Both parents were healthy and came from the same small town in Sicily but denied consanguinity.</Attribute>
              <Citation>
                <ID Source="PubMed">17717710</ID>
              </Citation>
              <XRef DB="OMIM" ID="604360" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Spanish patient with SPG11, Hehr et al. (2007) identified compound heterozygosity for the 733delAT mutation and 1-bp insertion (2472insT; 610844.0005) of exon 14 of the SPG11 gene, resulting in frameshift and premature termination.</Attribute>
              <Citation>
                <ID Source="PubMed">18067136</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Boukhris et al. (2008) identified a homozygous 733delAT mutation in affected members of 3 Tunisian families of Arab origin with SPG11.</Attribute>
              <Citation>
                <ID Source="PubMed">18332254</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 2 French sibs (family FSP117) with spastic paraplegia-11, Stevanin et al. (2007) identified compound heterozygous mutations in the SPG11 gene: a 2-bp deletion (c.733_734delAT) in exon 4, predicted to result in a frameshift and premature termination (Met245ValfsTer), and R1992X (610844.0011).</Attribute>
              <Citation>
                <ID Source="PubMed">17322883</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 2 Japanese sibs, born of consanguineous parents (family TK005), with autosomal recessive juvenile amyotrophic lateral sclerosis-5 (ALS5; 602099), Orlacchio et al. (2010) identified compound heterozygosity for the R1992X and c.733_734delAT mutations in the SPG11 gene. Functional studies of the variants and studies of patient cells were not performed.</Attribute>
              <Citation>
                <ID Source="PubMed">20110243</ID>
              </Citation>
              <XRef DB="OMIM" ID="602099" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <Name>SPG11, 2-BP DEL, 733AT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 733AT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="610844.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="461277" SubmissionDate="2019-05-17" DateLastUpdated="2019-05-20" DateCreated="2015-10-05">
        <ClinVarSubmissionID localKey="610844.0004_AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE" title="SPG11, 2-BP DEL, 733AT_AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE" />
        <ClinVarAccession Accession="SCV000249579" DateUpdated="2019-05-20" DateCreated="2015-10-05" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 27-year-old Italian opposite-sex dizygotic twins with autosomal recessive spastic paraplegia-11 (SPG11; 604360), Del Bo et al. (2007) identified a homozygous 2-bp deletion (733delAT) in exon 4 of the SPG11 gene, resulting in a frameshift and premature termination at codon 247. The sibs had onset of ataxia and cognitive impairment at ages 12 and 15 years, respectively. The disorder progressed rapidly, leading to spastic paraplegia, dysarthria, and peripheral neuropathy. Both were wheelchair-bound in their early twenties. Brain MRI showed thin corpus callosum and cortical atrophy in both sibs. Both parents were healthy and came from the same small town in Sicily but denied consanguinity.</Attribute>
              <Citation>
                <ID Source="PubMed">17717710</ID>
              </Citation>
              <XRef DB="OMIM" ID="604360" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Spanish patient with SPG11, Hehr et al. (2007) identified compound heterozygosity for the 733delAT mutation and 1-bp insertion (2472insT; 610844.0005) of exon 14 of the SPG11 gene, resulting in frameshift and premature termination.</Attribute>
              <Citation>
                <ID Source="PubMed">18067136</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Boukhris et al. (2008) identified a homozygous 733delAT mutation in affected members of 3 Tunisian families of Arab origin with SPG11.</Attribute>
              <Citation>
                <ID Source="PubMed">18332254</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 2 French sibs (family FSP117) with spastic paraplegia-11, Stevanin et al. (2007) identified compound heterozygous mutations in the SPG11 gene: a 2-bp deletion (c.733_734delAT) in exon 4, predicted to result in a frameshift and premature termination (Met245ValfsTer), and R1992X (610844.0011).</Attribute>
              <Citation>
                <ID Source="PubMed">17322883</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 2 Japanese sibs, born of consanguineous parents (family TK005), with autosomal recessive juvenile amyotrophic lateral sclerosis-5 (ALS5; 602099), Orlacchio et al. (2010) identified compound heterozygosity for the R1992X and c.733_734delAT mutations in the SPG11 gene. Functional studies of the variants and studies of patient cells were not performed.</Attribute>
              <Citation>
                <ID Source="PubMed">20110243</ID>
              </Citation>
              <XRef DB="OMIM" ID="602099" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <Name>SPG11, 2-BP DEL, 733AT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 733AT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="610844.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2866140" SubmissionDate="2020-11-14" DateLastUpdated="2021-05-16" DateCreated="2021-05-16">
        <ClinVarSubmissionID localKey="NM_025137.4:c.733_734del|OMIM:604360" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001451240" DateUpdated="2021-05-16" DateCreated="2021-05-16" Type="SCV" Version="1" SubmitterName="Paris Brain Institute, Inserm - ICM" OrgID="507826" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="6" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.4:c.733_734del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604360" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8526155</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5027720" SubmissionDate="2022-09-14" DateLastUpdated="2022-09-17" DateCreated="2022-09-17">
        <ClinVarSubmissionID localKey="NM_025137.3:c.733_734delAT|MedGen:C0037773" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002571974" DateUpdated="2022-09-17" DateCreated="2022-09-17" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18079167</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19438933</ID>
          </Citation>
          <Comment>Variant summary: SPG11 c.733_734delAT (p.Met245ValfsX2) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position are associated with Spastic Paraplegia in HGMD. The variant allele was found at a frequency of 6.8e-05 in 251452 control chromosomes (gnomAD). This frequency is not higher than expected for a pathogenic variant in SPG11 causing Hereditary Spastic Paraplegia, Type 11 (6.8e-05 vs 0.0011). c.733_734delAT has been reported in the literature in multiple individuals affected with Hereditary Spastic Paraplegia (examples: Boukhris_2009 and Stevanin_2008). These data indicate that the variant is very likely to be associated with disease. Eight submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic (n=7) and likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.3:c.733_734delAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0037773" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12061022</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5041615" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_025137.4:c.733_734del|OMIM:616668" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002580705" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="312262720" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.4:c.733_734del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616668" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PM3, PM2_SUP, PP1</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5407029" SubmissionDate="2022-12-08" DateLastUpdated="2022-12-17" DateCreated="2022-12-17">
        <ClinVarSubmissionID localKey="NM_025137.4:c.733_734del|OMIM:604360" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002764224" DateUpdated="2022-12-17" DateCreated="2022-12-17" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.4:c.733_734del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604360" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12366175</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5407028" SubmissionDate="2022-12-08" DateLastUpdated="2022-12-17" DateCreated="2022-12-17">
        <ClinVarSubmissionID localKey="NM_025137.4:c.733_734del|OMIM:616668" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002764223" DateUpdated="2022-12-17" DateCreated="2022-12-17" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.4:c.733_734del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616668" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12366175</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5449962" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_025137.4:c.733_734del|OMIM:602099;604360;616668" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002795969" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.4:c.733_734del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602099" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604360" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616668" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7329935" SubmissionDate="2023-04-28" DateLastUpdated="2023-11-04" DateCreated="2023-11-04">
        <ClinVarSubmissionID localKey="NM_001160227.1:c.733_734del|OMIM:604360" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003920827" DateUpdated="2023-11-04" DateCreated="2023-11-04" Type="SCV" Version="1" SubmitterName="Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL)" OrgID="509068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001160227.1:c.733_734del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604360" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13188883</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="484582" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="351696|MedGen:C1858479" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000259624" DateUpdated="2024-02-14" DateCreated="2015-10-11" Type="SCV" Version="8" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19105190</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20110243</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22154821</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26556829</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17322883</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17717710</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18067136</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18079167</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18332254</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18835492</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19105190</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19438933</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20110243</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22175763</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22237444</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22696581</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24833714</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27071356</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Met245Valfs*2) in the SPG11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPG11 are known to be pathogenic (PMID: 19105190, 20110243, 22154821, 26556829). This variant is present in population databases (rs312262720, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with autosomal recessive hereditary spastic paraplegia with thin corpus callosum, also known as ARHSP-TCC and juvenile amyotrophic lateral sclerosis (PMID: 17322883, 17717710, 18067136, 18079167, 18332254, 18835492, 19105190, 19438933, 20110243, 22175763, 22237444, 22696581, 24833714, 27071356). ClinVar contains an entry for this variant (Variation ID: 1112). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.44949428_44949429del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1858479" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1119191" SubmissionDate="2017-03-10" DateLastUpdated="2017-12-10" DateCreated="2017-12-10">
        <ClinVarSubmissionID localKey="NM_025137.3:c.733_734del|Orphanet:ORPHA685" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000574449" DateUpdated="2017-12-10" DateCreated="2017-12-10" Type="SCV" Version="1" SubmitterName="Unit for Genetic &amp; Epidemiological Research on Neurological Disorders, Instituto de Investigao e Inovao em Sade" OrgID="506106" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">28832565</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Morais et al. (Eur J Hum Genet. 2017)</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">28832565</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.3:c.733_734del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA685" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28832565</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28832565</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>HSP_Cohort</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2297794" SubmissionDate="2019-10-03" DateLastUpdated="2020-03-01" DateCreated="2020-03-01">
        <ClinVarSubmissionID localKey="4647_1|OMIM:604360" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001164580" DateUpdated="2020-03-01" DateCreated="2020-03-01" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17717710</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20110243</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17322883</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18079167</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22175763</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18332254</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24833714</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22696581</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22237444</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18067136</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18835492</ID>
          </Citation>
          <Comment>The heterozygous p.Met245ValfsTer2 variant in SPG11 was identified by our study in the compound heterozygous state, along with another pathogenic variant, in two siblings with spastic paraplegia. The presence of this variant in combination with a reported pathogenic variant and in an individual with spastic paraplegia increases the likelihood that the p.Met245ValfsTer2 variant is pathogenic. The p.Met245ValfsTer2 variant in SPG11 has been well-reported in the literature. This variant has been reported in greater than 22 individuals from Italy, Japan, France, Tunisia, Sicily, Korea, Spain, China, and Portugal with spastic paraplegia in the homozygous and compound heterozygous state, segregated with disease in 12 affected relatives from 5 families (PMID: 17717710, 20110243, 17322883, 18079167, 22175763, 18332254, 24833714, 22696581, 22237444, 18067136, 18835492), but has been identified in 0.006133% (17/277208) of chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs312262720). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID: 1112). This variant is predicted to cause a frameshift, which alters the proteins amino acid sequence beginning at position 245 and leads to a premature termination codon 2 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the SPG11 gene is an established disease mechanism in autosomal recessive spastic paraplegia. In summary, the p.Met245ValfsTer2variant is pathogenic based off of our findings, multiple reports of pathogenicity in ClinVar, and the literature. ACMG/AMP Criteria applied: PM2, PVS1, PM3, PP1_Moderate (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>WES</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="15" alternateAllele="-" referenceAllele="AT" start="44949428" stop="44949429" variantLength="2" />
          </Location>
          <OtherNameList>
            <Name>p.Met245ValfsTer2</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604360" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6387569</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3453523" SubmissionDate="2021-09-09" DateLastUpdated="2022-01-22" DateCreated="2022-01-22">
        <ClinVarSubmissionID localKey="9710642|HPO:HP:0011442" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001755640" DateUpdated="2022-01-22" DateCreated="2022-01-22" Type="SCV" Version="1" SubmitterName="Kariminejad - Najmabadi Pathology &amp; Genetics Center" OrgID="506221" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.4:c.733_734delAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="HP" ID="HP:0011442" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10350875</SubmissionName>
          <SubmissionName>SUB9989790</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4118195" SubmissionDate="2022-03-15" DateLastUpdated="2022-03-19" DateCreated="2022-03-19">
        <ClinVarSubmissionID localKey="2022-02039|MONDO:0019064" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002105782" DateUpdated="2022-03-19" DateCreated="2022-03-19" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, The Hospital for Sick Children" OrgID="1043" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.3:c.733_734delAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0019064" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11183483</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="97481" SubmissionDate="2013-03-26" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_025137.3:c.733_734delAT_NBK1210" title="NM_025137.3:c.733_734delAT and Spastic Paraplegia 11" />
        <ClinVarAccession Accession="SCV000058206" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">17322883</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">17717710</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">18067136</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">18079167</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">18332254</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">18835492</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">19105190</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">20301389</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="BookShelf">NBK1210</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="312262720" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.3:c.733_734delAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1858479" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="617093" SubmissionDate="2021-11-03" DateLastUpdated="2023-03-04" DateCreated="2016-10-09">
        <ClinVarSubmissionID localKey="GDXSV:206858" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000322440" DateUpdated="2023-03-04" DateCreated="2016-10-09" Type="SCV" Version="9" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense-mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 17717710, 18332254, 20110243, 22175763, 17322883, 18067136, 27071356, 31227335, 31289639, 31969655, 29980238, 31589614)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:732340</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.3:c.733_734del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_50_20210924044205</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_68_20211103121700</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7160200" SubmissionDate="2023-02-19" DateLastUpdated="2023-03-11" DateCreated="2023-03-11">
        <ClinVarSubmissionID localKey="20181|OMIM:604360" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003836354" DateUpdated="2023-03-11" DateCreated="2023-03-11" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.4:c.733_734del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604360" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12876118</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7574683" SubmissionDate="2023-10-19" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="11100145034" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004047947" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The frameshift deletion p.M245Vfs*2 in SPG11 (NM_025137.4) has been previously reported in many individuals affected with autosomal recessive hereditary spastic paraplegia with thin corpus callosum, also known as ARHSP-TCC (Stevanin et al, 2007;Del Bo et al. 2007). This variant is predicted to cause loss of normal protein function through protein truncation caused a frameshift mutation. The frame shifted sequence continues 2 residues until a stop codon is reached. The p.M245Vfs*2 variant is a loss of function variant in the gene SPG11, which is intolerant of Loss of Function variants. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002313" />
              </Trait>
              <Comment>A 19 year old male. Consanguinity- Present. Clinical indication- History of difficulty in sitting down, difficulty in standing up, imbalance while walking, swallowing, slippage of footwear, tremors in upper limbs. Investigations- Mild intellectual disability, mild wasting of hand muscles, Gait-spastic gait. MRI- Dorso-Lumbar spine s/o mild posterior disc bulge of L4-L5 causing mild ventral thecal sac indentation. Clinical impression- Hereditary spastic paraparesis</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.4:c.733_734del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604360" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13901154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2853083" SubmissionDate="2024-04-20" DateLastUpdated="2024-05-01" DateCreated="2020-11-21">
        <ClinVarSubmissionID localKey="a722947|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001444991" DateUpdated="2024-05-01" DateCreated="2020-11-21" Type="SCV" Version="4" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17322883</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18332254</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20110243</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24833714</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29980238</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31289639</ID>
          </Citation>
          <Comment>The c.733_734delAT (p.M245Vfs*2) alteration, located in coding exon 4 of the SPG11 gene, results from a deletion of 2 nucleotides from position 733 to 734, causing a translational frameshift with a predicted alternate stop codon after 2 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from the Genome Aggregation Database (gnomAD), the c.733_734delAT alteration was observed in 0.006% (18/282852) of total alleles studied. In multiple individuals with spastic paraplegia with thin corpus callosum, this alteration has been detected in the homozygous state or in conjunction with a second disease-causing allele (Stevanin, 2007; Boukhris, 2008; Pensato, 2014; Dong, 2018; Wei, 2019). This alteration was also identified in a patient meeting diagnostic criteria for amyotrophic lateral sclerosis (ALS) and a brain MRI which was negative for thin corpus callosum and white matter abnormalities; this individual was also heterozygous for a nonsense variant in SPG11 (Orlacchio, 2010). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.3:c.733_734delAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_2</SubmissionName>
          <SubmissionName>NovelandUpdateExomeDeposit_ExomeProgenyThrough080120</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3442487" SubmissionDate="2021-04-26" DateLastUpdated="2024-06-17" DateCreated="2021-07-18">
        <ClinVarSubmissionID localKey="nvtapin_15199_2" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001749380" DateUpdated="2024-06-17" DateCreated="2021-07-18" Type="SCV" Version="2" SubmitterName="GenomeConnect - Invitae Patient Insights Network" OrgID="508034" OrganizationCategory="patient registry" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment>Variant interpreted as Pathogenic and reported on 05-07-2018 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">50</Age>
              <Age Type="maximum" age_unit="years">59</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>male</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Diagnostic</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <TypePlatform>Gene Panel Sequencing</TypePlatform>
              <MethodType>phenotyping only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2018-05-07" integerValue="500031">Invitae</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet DateLastEvaluated="2019-05-09" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000496" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000517" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000504" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000545" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000360" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003124" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002721" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002242" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0410009" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0009127" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0010674" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000135" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000014" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003110" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000707" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0011443" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001276" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002354" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0100022" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000739" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000738" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001787" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0011438" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.3:c.733_734del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1858479" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1865864" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9483450</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0100022" MappingRef="HP">
        <MedGen CUI="C0026650" Name="Movement disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002354" MappingRef="HP">
        <MedGen CUI="C0233794" Name="Memory impairment" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1333315" TraitType="Disease" MappingType="XRef" MappingValue="604360" MappingRef="OMIM">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000517" MappingRef="HP">
        <MedGen CUI="C0549651" Name="Abnormal lens morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Disease" MappingType="XRef" MappingValue="C1858479" MappingRef="MedGen">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000014" MappingRef="HP">
        <MedGen CUI="C0149632" Name="Abnormality of the bladder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1119191" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA685" MappingRef="Orphanet">
        <MedGen CUI="C0037773" Name="Hereditary spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="617093" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002721" MappingRef="HP">
        <MedGen CUI="C0021051" Name="Immunodeficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5407028" TraitType="Disease" MappingType="XRef" MappingValue="616668" MappingRef="OMIM">
        <MedGen CUI="C5569024" Name="Charcot-Marie-Tooth disease axonal type 2X" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="461277" TraitType="Disease" MappingType="Name" MappingValue="AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE" MappingRef="Alternate">
        <MedGen CUI="C1865864" Name="Amyotrophic lateral sclerosis type 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000739" MappingRef="HP">
        <MedGen CUI="C0003467" Name="Anxiety" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0410009" MappingRef="HP">
        <MedGen CUI="C4073188" Name="Abnormality of the somatic nervous system" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4118195" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0019064" MappingRef="MONDO">
        <MedGen CUI="C0037773" Name="Hereditary spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="21321" TraitType="Disease" MappingType="Name" MappingValue="SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE" MappingRef="Preferred">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000360" MappingRef="HP">
        <MedGen CUI="C0040264" Name="Tinnitus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="484582" TraitType="Disease" MappingType="XRef" MappingValue="C1858479" MappingRef="MedGen">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5041615" TraitType="Disease" MappingType="XRef" MappingValue="616668" MappingRef="OMIM">
        <MedGen CUI="C5569024" Name="Charcot-Marie-Tooth disease axonal type 2X" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011438" MappingRef="HP">
        <MedGen CUI="C4023357" Name="Maternal teratogenic exposure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000135" MappingRef="HP">
        <MedGen CUI="C0020619" Name="Hypogonadism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000496" MappingRef="HP">
        <MedGen CUI="C0497202" Name="Abnormality of eye movement" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011443" MappingRef="HP">
        <MedGen CUI="C4023353" Name="Abnormality of coordination" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5449962" TraitType="Disease" MappingType="XRef" MappingValue="602099" MappingRef="OMIM">
        <MedGen CUI="C1865864" Name="Amyotrophic lateral sclerosis type 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002242" MappingRef="HP">
        <MedGen CUI="C4316788" Name="Abnormal intestine morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7160200" TraitType="Disease" MappingType="XRef" MappingValue="604360" MappingRef="OMIM">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3453523" TraitType="Disease" MappingType="XRef" MappingValue="HP:0011442" MappingRef="HP">
        <MedGen CUI="C4023354" Name="Abnormal central motor function" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000545" MappingRef="HP">
        <MedGen CUI="C0027092" Name="Myopia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7329935" TraitType="Disease" MappingType="XRef" MappingValue="604360" MappingRef="OMIM">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2853083" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5027720" TraitType="Disease" MappingType="XRef" MappingValue="C0037773" MappingRef="MedGen">
        <MedGen CUI="C0037773" Name="Hereditary spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001787" MappingRef="HP">
        <MedGen CUI="C0549629" Name="Abnormal delivery" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5449962" TraitType="Disease" MappingType="XRef" MappingValue="604360" MappingRef="OMIM">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0010674" MappingRef="HP">
        <MedGen CUI="C4023747" Name="Abnormal curvature of the vertebral column" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1333315" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002355" MappingRef="Human Phenotype Ontology">
        <MedGen CUI="C0311394" Name="Difficulty walking" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574683" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002313" MappingRef="HP">
        <MedGen CUI="C0037771" Name="Spastic paraparesis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000707" MappingRef="HP">
        <MedGen CUI="C0497552" Name="Abnormality of the nervous system" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7574683" TraitType="Disease" MappingType="XRef" MappingValue="604360" MappingRef="OMIM">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000504" MappingRef="HP">
        <MedGen CUI="C4025846" Name="Abnormality of vision" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5449962" TraitType="Disease" MappingType="XRef" MappingValue="616668" MappingRef="OMIM">
        <MedGen CUI="C5569024" Name="Charcot-Marie-Tooth disease axonal type 2X" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001276" MappingRef="HP">
        <MedGen CUI="C0026826" Name="Hypertonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1333315" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002061" MappingRef="Human Phenotype Ontology">
        <MedGen CUI="C1271100" Name="Lower limb spasticity" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2297794" TraitType="Disease" MappingType="XRef" MappingValue="604360" MappingRef="OMIM">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003110" MappingRef="HP">
        <MedGen CUI="C4025655" Name="Abnormality of urine homeostasis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5407029" TraitType="Disease" MappingType="XRef" MappingValue="604360" MappingRef="OMIM">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="97481" TraitType="Disease" MappingType="XRef" MappingValue="C1858479" MappingRef="MedGen">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003124" MappingRef="HP">
        <MedGen CUI="C0020443" Name="Hypercholesterolemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Disease" MappingType="XRef" MappingValue="C1865864" MappingRef="MedGen">
        <MedGen CUI="C1865864" Name="Amyotrophic lateral sclerosis type 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0009127" MappingRef="HP">
        <MedGen CUI="C4024582" Name="Abnormality of the musculature of the limbs" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2866140" TraitType="Disease" MappingType="XRef" MappingValue="604360" MappingRef="OMIM">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3442487" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000738" MappingRef="HP">
        <MedGen CUI="C0018524" Name="Hallucinations" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

